On August 29-31, 2019, the 16th Zhejiang Primary Medical Equipment Exhibition (ZIMEX) was grandly held in Hangzhou. ZIMEX aims to introduce advanced technology at home and abroad, display the latest medical equipment, in order to strengthen international technology and information exchanges, expand external development, prosper the medical market in our province, and promote the accelerated development of our province's medical and health undertakings. For this reason, representatives of relevant units inside and outside Zhejiang Province were also invited to participate in this exhibition.

This exhibition will exhibit the advanced scientific research and medical equipment samples of participating companies (manufacturers), display relevant pictures and materials, and hold various forms of medical technology information lectures and seminars, which are the development of the medical and health industry in our province. A miniature will also serve as a weather vane. The exhibition builds an interactive platform between hospitals and enterprises, so that Chinese and foreign parties can take this opportunity to carry out extensive medical technology and information exchanges, thereby establishing a stable cooperative relationship. This also highlights the role of the exhibition and enhances the international influence of the exhibition.

Aocheng Biology (1A070), as a highlight of this expo, attracted many guests from inside and outside the province to visit. Ao Cheng has won wide recognition from the guests with his professional skills and dedicated attitude.

At this exhibition, Ningbo Aocheng brought a special product Placental Growth Factor (PlGF) detection reagent.Placental growth factor is used to assess placental function. It can effectively predict more than 90% of preeclampsia by combining PlGF, maternal factors, MAP, and UtA-PI in the first trimester.The program was recommended by the International Federation of Obstetrics and Gynecology (FIGO) guidelines. Aucheer's PlGF detection reagent will usher in a new era of preeclampsia risk assessment and management.

The exhibition showcased three major immunological detection platforms and detection instruments: detection technologies include time-resolved fluorescence immunity, microfluidic technology and magnetic particle acridinium chemiluminescence. At the same time, the focus of this releaseAucheer PlGF product detection mode from single-channel iteration to fully automatic, detection throughput from 20T/hour iteration to 180T/hour, detection accuracy CV value from CV<15% iteration to CV<5%,To meet the different needs of users in clinical medical institutions,Provide innovative solutions for clinical diagnosis of women's and children's health in an all-round way.

Ningbo Aocheng Biotechnology Co., Ltd. is a high-tech biological enterprise focusing on the early detection, diagnosis, prevention and monitoring of diseases. By providing reliable, fast and convenient in vitro diagnostic products, it can provide accurate test results for diagnosis and treatment.

At present, the company's biomedical team continues to conduct in-depth exploration and prospective research in the field of high-risk diseases for pregnant women such as hypertension.We will be committed to providing professional clinical diagnosis solutions for women and children's health. Promote the standardized management of perinatal preeclampsia in my country, and contribute to the predictive management of preeclampsia in the world.